Cancer vaccine trials begin for people with Lynch syndrome

Clinical trials of next-generation cancer vaccines have begun in the US and UK, targeting people with Lynch syndrome — a genetic condition that significantly raises the risk of multiple cancers at a young age. The vaccines represent a new form of immunotherapy aimed at preventing cancer before it develops.